Skip to main content
. 2020 Jan 24;11(3):585–606. doi: 10.1007/s13300-020-00764-7
Insulin distress, an emotional response of the patient to the suggested use of insulin, acts as a major barrier to insulin therapy in the management of DM. Addressing patient-, physician- and drug-related factors is important to overcome insulin distress.
A group of endocrinologists came together at an international meeting held in India to develop a tool kit that would aid a practitioner in implementing insulin motivation strategies at different stages of the patient journey through insulin therapy.
Bringing in positive behavioral change by motivating the patient to improve treatment adherence helps overcome insulin distress and achieve treatment goals.